Skip to main content
OpenTrials
Completed

NCT Number: NCT00828425

Management of Diabetes Mellitus Patients With Retinopathy

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

* which medication are used to keep blood pressure under control? * which medication are used for metabolic control? * the average control level of metabolism and blood pressure is compliant with the international guidelines? * laser photocoagulation plays a role in the control of metabolism and blood pressure? * there are differences in the control of metabolism and blood pressure between patients with DM I or DM II? * there is an influence of renal failure on the choose of medication?

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Diegten, Basel-Landschaft, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetic patients
  • Diabetic retinopathy

Treatment and study plan

Primary outcomes

  1. Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight

    Time frame: every 3 months

  2. evolution of diabetic retinopathy

    Time frame: every 3 months

Secondary outcomes

  1. concomitant medication

    Time frame: every 3 months

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start
2008
Study completion
2009
First posted
Jan 26, 2009
Registry last updated
Aug 18, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.